Surgical Sutures Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global surgical sutures market growth forecasted to transform from $4.0 billion in 2023 to $5.5 billion by 2028, driven by a CAGR of 6.4%. The growth of the surgical suture market is fueled by the rising prevalence of chronic diseases and an increasing number of surgical procedures worldwide. Advances in surgical techniques, especially the shift towards minimally invasive procedures, are driving demand for specialized and innovative sutures. Emerging economies with expanding healthcare infrastructure and a growing focus on quality healthcare services are significant contributors to market growth. Additionally, heightened awareness among healthcare professionals about the importance of effective sutures in preventing complications is boosting market expansion. In summary, demographic trends, technological advancements, and healthcare infrastructure development are key drivers propelling the growth of the surgical suture market. However, amidst this optimistic landscape, certain restraints merit consideration. Stringent regulatory requirements pose challenges for market entry, particularly for new players.

Surgical Sutures Market – Global Outlook Through 2028

To know about the assumptions considered for the study, Request for Free Sample Report

Promising Opportunities in the Surgical Sutures Market

Market Dynamics

Driver: Rising surgical procedures and trauma cases to drive the market

The surgical suture market is thriving due to several key drivers. Firstly, the increasing prevalence of chronic diseases worldwide, coupled with a growing aging population, has led to a surge in surgical procedures. This heightened demand for medical interventions, in turn, fuels the necessity for effective wound closure solutions, with surgical sutures playing a central role. Secondly, ongoing technological advancements in suture materials have revolutionized the landscape of surgical wound closure. The development of innovative materials and techniques provides healthcare professionals with a diverse array of options, enhancing the precision, safety, and efficacy of suturing procedures. These advancements cater to the evolving needs of surgeons across various specialties and contribute to the market's overall growth. Moreover, the continuous expansion of healthcare infrastructure globally has increased access to surgical interventions. The improved availability of healthcare facilities, along with the rising awareness of advanced medical treatments, further stimulates the demand for surgical sutures.

Aging population, chronic diseases and rise in surgical procedures to drive the market.

The concurrent rise in chronic diseases and the demographic shift towards an aging population are shaping a transformative landscape in healthcare. The surge in chronic conditions, spanning cardiovascular disorders, diabetes, and malignancies, is propelling a global increase in surgical interventions. Simultaneously, the expanding aging demographic is contributing to a higher incidence of age-related health concerns, necessitating an elevated frequency of surgeries, including joint replacements, cardiac procedures, and various orthopedic interventions. This dual dynamic is steering healthcare professionals towards an intensified demand for effective wound closure solutions, with surgical sutures at the forefront. In this era of evolving healthcare challenges, the demand for optimal wound closure solutions is becoming increasingly critical, with surgical sutures emerging as indispensable tools in addressing the complex healthcare needs posed by chronic diseases and the aging population.

Restraint: Availability of Alternative Wound Closure Methods

The landscape of wound closure methods in healthcare has witnessed a notable evolution with the rising prominence of alternative techniques beyond traditional sutures. Surgical staples, tissue adhesives, and hemostats have emerged as formidable alternatives, each offering unique advantages tailored to specific surgical contexts. Surgical staples, characterized by their rapid application and secure closure, find preference in procedures where expediency is crucial, such as in certain types of skin closures and abdominal surgeries. Tissue adhesives, known for their simplicity and reduced tissue trauma, are often favored in instances where a more cosmetic outcome is desired, particularly in dermatological and plastic surgery procedures. Hemostats, designed to control bleeding, play a pivotal role in various surgical scenarios, enhancing precision and efficiency. The availability of these alternatives introduces a nuanced dimension to surgeons' choices, influencing preferences based on factors like procedural requirements, patient outcomes, and surgeons' familiarity with specific methods. Consequently, this diversification in wound closure options is reshaping the dynamics of the surgical suture market, challenging the conventional dominance of traditional sutures and prompting a reevaluation of preferred techniques in contemporary surgical practice. As healthcare professionals navigate this spectrum of choices, the impact on the market share of traditional surgical sutures underscores the ongoing paradigm shift towards a more diversified and tailored approach to wound closure methodologies.

Opportunity: Low and Middle-Income Countries have opportunities for growth of this market

The surgical suture market, in its journey towards transformation, encounters a spectrum of opportunities that extend beyond conventional boundaries, with a particular focus on low and middle-income countries (LMICs). Technological advancements, including smart sutures and biodegradable materials, offer a pathway for innovation that aligns with the evolving healthcare needs in LMICs. As these countries witness increased adoption of minimally invasive surgeries (MIS), there emerges a unique opportunity for specialized sutures that cater to the specific requirements of these procedures, fostering affordability and accessibility. The burgeoning global healthcare expenditure, particularly in LMICs, contributes to the expansion of the market by enhancing healthcare infrastructure and embracing advanced surgical techniques. The emphasis on value-based healthcare resonates profoundly in LMICs, where efficient and cost-effective wound closure solutions become imperative. Furthermore, the demographic shift towards aging populations in these regions necessitates tailored solutions, presenting an opportunity for the surgical suture market to address unique challenges associated with geriatric surgical interventions. In navigating these opportunities, stakeholders in the surgical suture market play a crucial role in bridging healthcare gaps and contributing to the advancement of surgical care in low and middle-income countries.

Challenge: High Market Competition and Pricing Pressures

The surgical suture industry faces a formidable challenge as it grapples with heightened market competition and substantial pricing pressures. The prevalence of numerous manufacturers vying for market share intensifies competition, creating an environment where pricing strategies become pivotal for survival. The industry's challenge lies in maintaining product quality and innovation while simultaneously managing cost structures to remain competitive in a market where price sensitivity among healthcare providers is a significant determinant. As manufacturers strive to meet the increasing demand for surgical sutures, finding a delicate balance between affordability and sustaining profit margins becomes a strategic imperative. The challenge further extends to navigating the delicate equilibrium between product differentiation and cost-effectiveness as healthcare professionals and facilities seek value without compromising on the efficacy and reliability of surgical sutures. In this fiercely competitive landscape, industry players are compelled to explore innovative solutions and operational efficiencies to overcome the hurdles posed by market competition and pricing pressures, ensuring the continued advancement of wound closure technologies in the face of economic constraints.

Ecosystem/ Market Map

The ecosystem market map of the surgical suture market comprises the elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research and development organizations, and end users.

Manufacturers include the companies involved in the entire process of research, product development, optimization, and launch of products. Distributors include third parties and eCommerce companies linked with the manufacturers for the marketing of these digital pathology products and solutions. Research and product development includes in-house research facilities organizations, contract research organizations, and contract development manufacturing organizations, which play a key role in outsourcing research for product development to manufacturers. End users are areas where surgical sutures have major applications.

Source: Secondary Literature, Interviews with Experts, and MarketsandMarkets Analysis

Note: Research and Development is restricted to software only.

The surgical sutures industry, is projected to grow at a CAGR of 6.4% between 2023 and 2028.

The surgical sutures market is projected to reach USD 5.5 billion by 2028 from USD 4.0 billion in 2023, at a CAGR of 6.4% during the forecast period. The surgical suture market is expanding globally due to heightened demand from increased surgical procedures and the prevalence of chronic diseases, especially in minimally invasive approaches. Emerging economies with growing healthcare infrastructure and a focus on quality healthcare are major contributors. Additionally, the growing awareness among healthcare professionals about the vital role of effective sutures in preventing complications is driving market growth. In summary, demographic shifts, technological progress, and healthcare infrastructure development are key factors in the thriving market.

Surgical Sutures Thread segment accounted for a substantial share of the surgical sutures industry, by Product in 2022.

In 2022, the surgical suture thread segment played a significant role in the surgical sutures market, capturing a substantial share of the market by product. This prominence can be attributed to the pivotal role that suture threads play in wound closure during surgical procedures. Suture threads are integral components in stitching and securing incisions, facilitating the healing process. The high demand for these threads is fueled by their effectiveness in providing wound support, reducing the risk of complications, and promoting faster healing. The preference for suture threads is also driven by advancements in material technology, with manufacturers offering a variety of threads designed for specific surgical needs. Surgeons often choose suture threads based on factors such as tissue type, procedure complexity, and desired outcomes. As a result, the robust utilization of surgical suture threads reflects their crucial role in ensuring successful surgical outcomes, contributing significantly to their substantial market share in 2022.

Hospitals segment accounted for a considerable share in the surgical sutures industry, by end user in 2022.

In 2022, the hospitals segment held a considerable share of the surgical sutures market by end users, underscoring its significance in the healthcare landscape. This prominence is primarily attributed to the fundamental role that hospitals play as major hubs for surgical interventions and medical procedures. Hospitals are pivotal settings for a wide range of surgeries, from routine procedures to complex surgeries, necessitating the consistent and extensive use of surgical sutures. The high demand for surgical sutures in hospitals is driven by the sheer volume and diversity of surgeries conducted within these healthcare facilities.

Moreover, hospitals prioritize the use of high-quality and technologically advanced sutures to ensure effective wound closure, reduce the risk of infections, and promote optimal patient recovery. The substantial share of the surgical suture market held by hospitals is indicative of the ongoing reliance on these medical facilities for a wide array of healthcare services that require surgical interventions. Surgeons and medical practitioners in hospitals choose specific sutures based on the type of surgery, patient needs, and advancements in suture technology. Therefore, the hospitals segment's significant market share in 2022 underscores the central role these institutions play in driving the demand and utilization of surgical sutures.

Cardiovascular surgeries accounted for the largest share in surgical sutures industry by Application in 2022.

In 2022, the cardiovascular surgery segment held a substantial share of the surgical sutures market by application. This reflects the critical role of surgical sutures in intricate cardiovascular procedures, where precision and reliability are paramount. The specialized nature of cardiovascular surgeries demands advanced sutures tailored to address specific challenges, such as secure vessel closure and the prevention of complications. Surgeons prioritize high-quality sutures with excellent tensile strength and minimal tissue reactivity. The notable presence of the cardiovascular surgery segment in the market underscores the importance of tailored and effective sutures in ensuring the success of cardiovascular procedures.

North America dominated the Surgical Sutures Industry in 2022.

In 2022, North America emerged as the dominant force in the Surgical Sutures market, primarily due to its robust healthcare infrastructure, evolving regulatory environment, and increasing awareness of the significance of end-of-life planning. The region's well-established healthcare providers and systems have played a pivotal role in integrating Surgical Sutures discussions into patient care routines. Moreover, regulatory frameworks that facilitate Surgical Sutures and legal recognition of patient preferences have contributed to a favorable environment for advance directive adoption. The growing emphasis on patient autonomy, coupled with a shift towards person-centered healthcare, has spurred a higher demand for comprehensive advance directive solutions.

Surgical Sutures Market Analysis by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in the surgical sutures market include Ethicon, Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic Plc (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), Healthium MedTech Limited (India), Peters Surgical (France), Corza Medical (US), Boston Scientific Corporation (US), DemeTECH Corporation (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Smith & Nephew Plc (UK), CONMED Corporation (US), Mellon Medical B.V. (Netherlands), Unisur Lifecare Pvt. Ltd. (India), Assut Europe (UK), KatsanKatgüt Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Aqmen Medtech Pvt. Ltd. (India), Futura Surgicare Pvt. Ltd. (India), Anchora Medical Ltd. (Israel), Lotus Surgicals (India), Biosintex (Romania), and Meril Life Sciences Pvt. Ltd. (India).

Report Scope

The study categorizes the surgical sutures market to forecast revenue and analyze trends in each of the following submarkets

By Product

• Suture Thread
• Automated Suturing Devices

By Type

• Monofilament Sutures
• Multifilament Sutures

By Application

• Cardiovascular Surgery
• General Surgery
• Gynecological Surgery
• Orthopedic Surgery
• Ophthalmic Surgery
• Cosmetic & Plastic Surgery
• Other Applications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics & Physicians’ Offices

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Latin America
• Middle East and Africa

Recent Developments

• In January 2023, Ethicon, Inc. partnered with Microsoft (US) to further expand its digital surgery solutions.
• In March 2023, Medtronic plc (Ireland) signed a contract with Vizient (US) for the Touch Surgery Enterprise, allowing surgeons to use data to refine how surgery is taught and executed.
• In December 2021, DKSH (Switzerland) expanded its partnership with Healthium MedTtech Limited. This partnership will help Healthium to provide its products in Thailand, Cambodia, and Laos.
• In June 2021, Healthium acquired VitalCare (UK), a manufacturer of urology consumable care products, through its subsidiary Clinisupplies Ltd. With this acquisition, Healthium strengthened its presence in the urology segment in Europe and the US.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst